3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions

Abstract

A fine balance between bone resorption by osteoclasts and bone formation by osteoblasts maintains bone homeostasis. In patients with cherubism, gain-of-function mutations in 3BP2, which is encoded by SH3-domain binding protein 2 (SH3BP2), cause cystic lesions with activated osteoclasts that lead to craniofacial abnormalities. However, little is known about the function of wild-type 3BP2 in regulating bone homeostasis. Here we have shown that 3BP2 is required for the normal function of both osteoblasts and osteoclasts. Initial analysis showed that Sh3bp2 -/-mice developed osteoporosis as a result of reduced bone formation despite the fact that bone resorption was impaired. We demonstrated using reciprocal bone marrow chimeras, a cellintrinsic defect of the osteoblast and osteoclast compartments in vivo. Further, Sh3bp2 -/-osteoblasts failed to mature and form mineralized nodules in vitro, while Sh3bp2 -/-osteoclasts spread poorly and were unable to effectively degrade dentine matrix in vitro. Finally, we showed that 3BP2 was required for Abl activation in osteoblasts and Src activation in osteoclasts, and demonstrated that the in vitro defect of each cell type was restored by the respective expression of activated forms of these kinases. These findings reveal an unanticipated role for the 3BP2 adapter protein in osteoblast function and in coordinating bone homeostatic signals in both osteoclast and osteoblast lineages. Introduction3BP2 is an adapter protein that contains an N-terminal pleckstrin homology (PH) domain, a proline-rich stretch that binds to Src homology 3 (SH3) domain-containing proteins, and a C-terminal SH2 domain that binds to phosphotyrosine residues (1). 3BP2 was initially identified as a binding protein of the tyrosine kinase Abl (2). Work from our lab and others has identified the Src family kinases (SFKs), Syk, and the Vav family of Rho guanine nucleotide exchange factors (GEFs) as 3BP2-binding partners (1), all of which are known to play important roles in osteoclast function (3-5). Cherubism is a dominantly inherited syndrome characterized by excessive maxillary and mandibular bone resorption that is associated with activated osteoclasts and inflammatory cells creating interosseous cystic lesions (6). Single missense mutations in the gene encoding the adapter protein 3BP2 result in a gain-of-function alteration in the protein and is associated with the majority of cherubism patients (7). A mouse model that harbors 2 copies of a cherubism allele develops severe osteoporosis associated with highly activated osteoclasts (8).In order to elucidate the role of the wild-type form of 3BP2 in bone homeostasis, we analyzed loss-of-function mutant mice. As distinct from the osteoporotic phenotype of mice expressing the cherubism gain-of-function form of 3BP2 associated with active osteoclasts, we uncovered a complex bone phenotype in mice lacking 3BP2 characterized by loss-of-function in both the osteoclast and osteoblast lineages resulting in net decreased bone mineral density and reduced mechanical ...

The Adaptor 3BP2 Is Required for KIT Receptor Expression and Human Mast Cell Survival

“…This is a previously unrecognized link between MITF and 3BP2 expression and further studies are needed to dissect the mechanism. MITF is essential for osteoclast development and function (52) and 3BP2 is essential for coordinating bone homeostatic signals in both osteoclast and osteoblast lineages (53). In the bone metabolism context 3BP2 has been shown to regulate the bone marrow monocyte response to macrophage and osteoclast differentiation signals downstream of the receptors for macrophage colony-stimulating factor (M-CSF) and the receptor activator of nuclear factor kappaB ligand (RANKL) through mechanisms that involve control of extracellular signal-regulated kinase (ERK) and spleen tyrosine kinase (SYK) activity, respectively (11).…”

Claudin 18 is a novel negative regulator of bone resorption and osteoclast differentiation

“…The number (N) of nuclei per osteoclast in TRAP stained sections of the secondary spongiosa of proximal tibia in WT and Cldn-18 −/− mice at 4 weeks of age was determined as previously described (37). Briefly, twenty osteoclasts per sample were randomly selected with operator blinded, before osteoclasts were sorted based on 1–2 and 3–6 N.Nuclei per osteoclast.…”

Enhanced TLR-MYD88 Signaling Stimulates Autoinflammation in SH3BP2 Cherubism Mice and Defines the Etiology of Cherubism

“…Heterozygous mutations in the signaling adaptor protein SH3-domain binding protein 2 (SH3BP2) are responsible for the disorder (Ueki et al, 2001). SH3BP2, originally discovered as a protein that binds to ABL (Ren et al, 1993), has been found to interact with a variety of proteins including SYK (Deckert et al, 1998), VAV (Foucault et al, 2005), PLCγ1 and PLCγ2 (Deckert et al, 1998; Jevremovic et al, 2001), and SRC (Levaot et al, 2011a) in various cells. Phosphorylation of tyrosine residues in SH3BP2 by SYK modulates downstream signaling pathways (Maeno et al, 2003).…”